Cabbio Rio de Janeiro
Event details
CABBIO is the Latin American Center for Biotechnology, a regional initiative that brings together Argentina, Brazil, Colombia, Uruguay and other partner countries to strengthen scientific cooperation and innovation in biotechnology across Latin America. The programme fosters research collaboration, training, courses and joint projects that connect academic institutions, industry and government to advance biotechnological knowledge and capacity in the region.
Upcoming events
See allMeet INFORS HT at Single-Use Event Leiden 2026, where bioprocessing professionals come together to explore the latest developments in single-use technologies, cell culture and microbial systems. Discover our latest innovation, explore solutions for reliable and reproducible bioprocess development, and discuss your applications and challenges directly with our experts.
Meet INFORS HT at BPN Sydney (Bioprocessing Network) and discover new ways to bring greater control, transparency, and reproducibility to your bioprocess development. Get a first look at our latest innovation and don't miss Sebastian Schneider's presentation on control transparency and QbD-driven bioprocess development.
The Antibody Series 2026 is a premier international conference dedicated to antibody discovery and development, bringing together leading experts from academia, biotech, pharma and venture capital. The event showcases the latest innovations in antibody engineering, therapeutic development and emerging technologies, while providing a unique environment for scientific exchange, collaboration and high-level networking.
Meet INFORS HT at Single-Use Event Leiden 2026, where bioprocessing professionals come together to explore the latest developments in single-use technologies, cell culture and microbial systems. Discover our latest innovation, explore solutions for reliable and reproducible bioprocess development, and discuss your applications and challenges directly with our experts.
Meet INFORS HT at BPN Sydney (Bioprocessing Network) and discover new ways to bring greater control, transparency, and reproducibility to your bioprocess development. Get a first look at our latest innovation and don't miss Sebastian Schneider's presentation on control transparency and QbD-driven bioprocess development.
The Antibody Series 2026 is a premier international conference dedicated to antibody discovery and development, bringing together leading experts from academia, biotech, pharma and venture capital. The event showcases the latest innovations in antibody engineering, therapeutic development and emerging technologies, while providing a unique environment for scientific exchange, collaboration and high-level networking.